Southern Blotting Market Growth Accelerated by Increasing Biomedical Research
Southern Blotting Market Growth Accelerated by Increasing Biomedical Research
Increasing demand for personalized medicines along with rising funding for biomedical research across major economies has been fueling the adoption of southern blotting technique in recent years.

Southern blotting is a laboratory technique used to detect a specific DNA sequence in DNA samples through RNA or DNA separation and hybridization. It has become an essential technique in various biomedical fields including cancer research, genetic screening, and molecular biology, due to its high specificity and sensitivity. The global Southern Blotting Market is estimated to be valued at US$ 2.8 Bn in 2023 and is expected to exhibit a CAGR of 6.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:

Increasing demand for personalized medicines along with rising funding for biomedical research across major economies has been fueling the adoption of southern blotting technique in recent years. Growing incidence of genetic disorders and cancer globally has augmented the clinical utilization of southern blotting for disease diagnostics and management, thereby driving the market growth over the forecast period.

Segment Analysis
The global Southern blotting market is segmented based on product, type, application and end-user. The product segment is further divided into instruments, kits & reagents, and probes. Amongst these, the kits & reagents segment currently dominates the market owing to the frequent requirement of kits and reagents during Southern blotting procedures.

Key Takeaways
The Global Southern Blotting Market Size is expected to witness high growth.

Regional analysis: North America currently holds the largest share of the global Southern blotting market. This is attributed to the increasing investments in biological research and the presence of major biotech companies in the region. Asia Pacific is expected to witness the fastest growth over the forecast period owing to growing life science research activities, increasing healthcare expenditure, and growing investments by key players in the region.

Key players: Key players operating in the Southern blotting market are Ganeden, Sabinsa Corporation, UAS Laboratories, Sanzyme, Mitsubishi Chemical Foods Corporation, Mystical Biotech Pvt. Ltd., Aumgene Biosciences, Unique Biotech Ltd., Nebraska Culture, and Syngem Biotech.

For More Insights, Read: https://www.newswirestats.com/southern-blotting-market-trends-growth-and-regional-outlook-2023-2030/

 

Related Reports: https://shoutingstars.com/carbon-capture-and-storage-a-vital-climate-change-solution

disclaimer

What's your reaction?

Comments

https://www.timessquarereporter.com/assets/images/user-avatar-s.jpg

0 comment

Write the first comment for this!

Facebook Conversations